Optical Genome Mapping in Hematological Malignancies

Optical Genome Mapping in Hematological Malignancies

Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

Inclusion Criteria:

• Minor/Major Patients
• Patients with suspected hemopathies for whom we receive a sample for diagnosis in the chromosomal genetics laboratory or for whom a diagnosis of hemopathy has already been made.
• No objection made or consent given

Exclusion Criteria:

• Patients under judicial protection (guardianship, curatorship, ...),
• Refusal to participate